Fundraising FoxStimAire
Tucson, US · Founded 2018 · Delaware corporation · 2 known investors
Find your way into StimAire
Sign up to see every warm intro you have to StimAire
- Paths you didn't know you had: your email and LinkedIn already hold routes to the StimAire team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
StimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.
Founders & leadership
StimAire was founded in 2018 by Tarek Makansi.
Investors · 2
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2019
▶$1.6MraisedNov 2019 · 16 investors · Other Health CareRule 506(b)
▶$1.6MraisedNov 2019 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tarek MakansiExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $1.6M
- Minimum investment
- $3K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Inspire MedicalInspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective. The device is surgically placed by an ENT and configured by a sleep medicine professional.
Lunair MedicalLunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.
Stimdia MedicalStimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.
SomnairsleepSomnair develops a non-invasive neurostimulation device for treating obstructive sleep apnea that can be used at home. The device targets the millions of sleep apnea patients who fail or reject existing invasive treatments like CPAP therapy.
Companies working in the same space as StimAire.
In the news
Frequently asked questions
- What does StimAire do?
- StimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.
- Who founded StimAire?
- StimAire was founded by Tarek Makansi in 2018.
- Who are StimAire's investors?
- StimAire's investors include University Associates Venture Capital, UAVenture Capital.
- How much funding has StimAire raised?
- StimAire has disclosed $1.6M raised across 1 round.
- Where is StimAire headquartered?
- StimAire is headquartered in Tucson, US.